Cingulate’s Shane Schaffer joins the cast of the nationally televised Big Biz Show

Shane J. Schaffer, President and CEO of Cingulate (NASDAQ: CING), was a guest on the Big Biz Show program and was paired with national live streaming to discuss the most important asset in Cingulate’s Phase 3. CTx-1301because of treating ADHD. Schaffer managed to prove how farms work Precision Timed Release™ (PTR™) Over time, I set out to develop new generation pharmaceutical products. The discussion included work on the commercialization of CTx-1301 and the potential applications of the PTR™ technology in other therapeutic areas. The Big Biz Show, sponsored by Bob “Sully” Sullivan, is a live worldwide traffic partner of iHeart Radio and the American Forces Network.

Shane J. Schaffer, President and CEO of Cingulate (NASDAQ: CING), joined the Big Biz Show program and served nationally to speak about the key activity at Cingulate’s third phase. CTx-1301for the treatment of the TDAH. Schaffer removes the medication collection platform Precision Timed Release™ (PTR™) The company aims to supply the next generation of agricultural products. The discussion includes the aircraft for commercialization of the CTx-1301 and the potential applications of the PTR™ technology in other therapeutic areas. The Big Biz Show, presented by Bob “Sully” Sullivan, broadcasts to a global level via social networks such as iHeart Radio and the American Forces Network.

J. (Shane J. Schaffer) Cingulate (NASDAQ: CING) and CEO of ADHD has been with Cingulate for 3 years CTx-1301I started the show with the Big Biz Show and the show. 샤퍼는 차세대 제약 제품을 발전scribed 키기 위한 회사의 정밀 타임 릴리스™(PTR™) 약물 전달 플랫폼을 강조했습니다. The new CTx-1301 app is designed for use with the PTR™ app and for use with the PTR™ app 되었습니다. Bob “Sully” Sullivan was a member of the Big Biz Show and iHeart Radio and American Forces Network.

Shane J. Schaffer, President and PDG of Cingulate (NASDAQ: CING), appeared on the Big Biz Show, a nationally syndicated group, to discuss the Cingulate market in Phase 3, CTx-1301for the properties of TDAH. Schaffer worked before the medical treatment platform Precision Timed Release™ (PTR™) The company is ready to advance new generation pharmaceutical products. The discussion includes plans for the commercialization of CTx-1301 and potential applications of the PTR™ technology in other therapeutic areas. The Big Biz Show, animated by Bob “Sully” Sullivan, is distributed worldwide through partners iHeart Radio and the American Forces Network.

Shane J. Schaffer, Chairman and CEO of Cingulate (NASDAQ: CING), appeared on the nationally syndicated Big Biz Show to discuss Cingulate’s leading Phase 3 asset, CTx-1301to discuss the treatment of ADHD. Schaffer hob cutter Precision Timed Release™ (PTR™) The Company’s drug delivery platform aimed at advancing next-generation drug products. The discussion includes plans to commercialize CTx-1301 and possible applications of the PTR™ technology in other therapeutic areas. The Big Biz Show, hosted by Bob “Sully” Sullivan, airs worldwide on partners including iHeart Radio and the American Forces Network.